22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Tabakas

Matthew  Kreps

Investor Relations

Mr. James A. Mish

Corporate President & Member of Scientific Advisory Board

Mr. Lawrence D. Firestone

Chairman & Chief Executive Officer

Mr. Jonathan  Staffeldt

General Counsel/Chief Legal Officer

Mr. John J. Miller

Chief Operating Officer & Executive Officer

Mr. Daniel J. Otto

Chief Financial Officer

Mr. James C. Morrison

Technical Advisor & Regulatory Affairs Consultant

Pavadinimas	Rinkos kapitalizacija
PT Gudang Garam Tbk	0M
KT&G Corporation	0.1M
British American Tobacco p.l.c.	0M
PT Hanjaya Mandala Sampoerna Tbk	0M
British American Tobacco p.l.c.	0M
Imperial Brands PLC	0M
PT Wismilak Inti Makmur Tbk	0M
Dazed, Inc.	0M
Humble & Fume Inc.	0M
Scandinavian Tobacco Group A/S	0M

22nd Century Group, Inc.

22nd Century Group, Inc. Konkurentų sąrašas

Pagrindiniai konkurentai